Company news
Kezar Life Sciences, Inc. news in 2023
Kezar Life Sciences, Inc.'s news releases, calls and decks from 2023, newest first.
Kezar Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
November 12, 2023
Kezar Life Sciences Announces Strategic Restructuring to Prioritize Clinical-Stage Assets and Extend Financial Runway and Appoints Christopher Kirk, Ph.D. as Chief Executive Officer
October 2, 2023
Kezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China, South Korea and Southeast Asia
September 19, 2023
Kezar Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update
August 9, 2023
Kezar Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update
May 10, 2023
Kezar Life Sciences Reports Fourth Quarter and Year End 2022 Financial Results and Provides Business Update
March 13, 2023
Kezar Life Sciences to Change Virtual R&D Day Date to March 15, 2023
March 12, 2023
Kezar Life Sciences to Host Virtual R&D Day on March 22, 2023
March 5, 2023